Dart Drug management
Executive Summary
Chairman Alvin Towle has resigned from the company "to pursue other interests," selling his holding in the 77-store drug chain, Dart announced Jan. 28. A veteran exec of the three major Wash., D.C. area chains -- Dart, Peoples and Drug Fair -- Towle was a principal in the $160 mil. purchase of Dart via a leverage buyout in 1984. He headed the drugstore operation until last October, when he shifted his efforts into the strategic planning area. Stephen Hansbrough, who together with Towle has been managing Dart Drug since it went private, has assumed Towle's position as chairman.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.